Inhalable oridonin-loaded poly(lactic-co-glycolic)acid large porous microparticles for in situ treatment of primary non-small cell lung cancer

Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancers. Traditional chemotherapy for this disease leads to serious side effects. Here we prepared an inhalable oridonin-loaded poly(lactic-co-glycolic)acid (PLGA) large porous microparticle (LPMP) for in situ treatment of NSCLC w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Lifei, Li, Miao, Liu, Xiaoyan, Du, Lina, Jin, Yiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237759/
https://www.ncbi.nlm.nih.gov/pubmed/28119812
http://dx.doi.org/10.1016/j.apsb.2016.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237759/
https://www.ncbi.nlm.nih.gov/pubmed/28119812
http://dx.doi.org/10.1016/j.apsb.2016.09.006

Ejemplares similares